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Abstract
Background/Objectives: Upon irradiation with visible light, the photosensitizer-peptide conjugate eosin-(KLAKLAK)2 kills a
broad spectrum of bacteria without damaging human cells. Eosin-(KLAKLAK)2 therefore represents an interesting lead
compound for the treatment of local infection by photodynamic bacterial inactivation. The mechanisms of cellular killing by
eosin-(KLAKLAK)2, however, remain unclear and this lack of knowledge hampers the development of optimized therapeutic
agents. Herein, we investigate the localization of eosin-(KLAKLAK)2 in bacteria prior to light treatment and examine the
molecular basis for the photodynamic activity of this conjugate.
Methodology/Principal Findings: By employing photooxidation of 3,3-diaminobenzidine (DAB), (scanning) transmission
electron microscopy ((S)TEM), and energy dispersive X-ray spectroscopy (EDS) methodologies, eosin-(KLAKLAK)2 is visualized
at the surface of E. coli and S. aureus prior to photodynamic irradiation. Subsequent irradiation leads to severe membrane
damage. Consistent with these observations, eosin-(KLAKLAK)2 binds to liposomes of bacterial lipid composition and causes
liposomal leakage upon irradiation. The eosin moiety of the conjugate mediates bacterial killing and lipid bilayer leakage by
generating the reactive oxygen species singlet oxygen and superoxide. In contrast, the (KLAKLAK)2 moiety targets the
photosensitizer to bacterial lipid bilayers. In addition, while (KLAKLAK)2 does not disrupt intact liposomes, the peptide
accelerates the leakage of photo-oxidized liposomes.
Conclusions/Significance: Together, our results suggest that (KLAKLAK)2 promotes the binding of eosin Y to bacteria cell
walls and lipid bilayers. Subsequent light irradiation results in membrane damage from the production of both Type I & II
photodynamic products. Membrane damage by oxidation is then further aggravated by the (KLAKLAK)2 moiety and
membrane lysis is accelerated by the peptide. These results therefore establish how photosensitizer and peptide act in
synergy to achieve bacterial photo-inactivation. Learning how to exploit and optimize this synergy should lead to the
development of future bacterial photoinactivation agents that are effective at low concentrations and at low light doses.
Citation: Johnson GA, Ellis A, Kim H, Muthukrishnan N, Snavely T, et al. (2014) Photoinduced Membrane Damage of E. coli and S. aureus by the Photosensitizer-
Antimicrobial Peptide Conjugate Eosin-(KLAKLAK)2. PLoS ONE 9(3): e91220. doi:10.1371/journal.pone.0091220
Editor: Michael Hamblin, MGH, MMS, United States of America
Received December 11, 2013; Accepted February 7, 2014; Published March 7, 2014
Copyright:  2014 Johnson et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the Robert A. Welch Foundation (Grant A-1769) (http://www.welch1.org/) and the Norman Hackerman Advanced Research
Program (http://www.thecb.state.tx.us/index.cfm?objectid = E55F9EE7-E488-6873-7D535561D9B426B8). The funders had no role in study design, data collection
and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: pellois@tamu.edu
Introduction
The rising incidence of drug resistant pathogens emphasizes the
urgent need for new approaches to antimicrobial killing [1–4].
One alternative to traditional antibiotics for topical microbial
killing is photodynamic inactivation (PDI), a therapeutic strategy
that combines photosensitizers (PS) and light. In this approach, PS
are compounds that produce reactive oxygen species (ROS) upon
irradiation [5]. These ROS can in turn cause cell death by
oxidizing biomolecules such as proteins, nucleic acids, and lipids
[5–7]. A limitation of PDI consists in the fact that light does not
penetrate tissues deeply. PDI is therefore not adequate for the
treatment of systemic infections. On the other hand, PDI has been
successfully applied to the treatment of acne [8–11], oral
disinfection [12], peptic, skin, and diabetic foot ulcers [13–15],
and blood decontamination [16–18]. PDI also kills antibiotic
resistant strains as effectively as their antibiotic sensitive counter-
parts [19–21], and repeated sub-lethal PDI treatments have failed
to produce resistant strains [22]. PDI therefore represents a
possible long-term approach for the treatment of local infections.
Additionally, applications of PDI to infections of the skin/soft
tissues and surgical sites may prove to be particularly valuable
when considering that these infections account for ,7–10% of
hospitalized patient infections [23] and 20–31% [24,25] of
healthcare-associated infections, respectively. PDI could play an
important role in these contexts to prevent, or reduce the
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likelihood of, subsequent systemic infections after passage of
organisms from the initial infection sites into the bloodstream [26].
A challenge in PDI consists of designing PS that have broad-
spectrum activity while also maintaining low phototoxicity towards
human cells. PS are often hydrophobic and generally have a
significant affinity for biological membranes [27,28]. Hydrophobic
PS are typically capable of binding Gram-positive bacteria and
photo-killing is often effective. However, these PS are often not
able to kill Gram-negative strains, presumably because the LPS-
rich cell wall constitutes a relatively impermeable barrier [29]. In
addition, hydrophobic PS often lack specificity in targeting
bacterial membranes, leading to unintended binding and damage
to human cells [30]. In order to promote binding to the negatively
charged surface of bacterial membranes, PS have been conjugated
to cationic polymers. For instance, PS have been conjugated to
poly-lysine (pL) and poly-ethyleneimine (PEI) [31–33], and certain
positively charged peptides such as cell-penetrating peptides
(CPPs) [34–36]. These cationic polymers improve the activity of
PS towards Gram-negative strains significantly [36]. However, the
phototoxicity of such polymer-PS conjugates towards human cells
remains problematic as human cells also have a high propensity to
bind and internalize these species [37–40].
Recently, the amphipathic antimicrobial peptide (AMP)
(KLAKLAK)2 conjugated to the photosensitizer eosin Y was
designed as a novel PDI agent [41]. This design was guided by the
notion that eosin Y, a rather hydrophilic PS, would not
significantly associate with membranes on its own. On the other
hand, AMPs are known to associate with bacteria more than with
human cells. A hypothesis was therefore that (KLAKLAK)2 might
target eosin Y to bacteria efficiently while avoiding association
with human cells. Indeed, efficient binding of eosin-(KLAKLAK)2
to both Gram negative E. coli and Gram positive S. aureus was
observed under conditions when eosin Y itself does not associate
with bacteria. Consequently, efficient photokilling of bacteria
(Gram negative E. coli, A. baumannii, and Ps. aeruginosa, and Gram
positive S. aureus and S. epidermidis) was achieved with eosin-
(KLAKLAK)2 upon light irradiation while similar treatments with
eosin Y did not cause cell killing. In contrast, eosin-(KLAKLAK)2
did not significantly associate with human cells (i.e. plasma
membrane binding and endocytic uptake are limited) and the
photokilling of human cells was minimal at the concentrations for
which more than 99.99% bacterial killing is achieved (e.g. 1 mM
eosin-(KLAKLAK)2 for 5-log reduction of 10
8 CFU/mL E. coli or
S. aureus cultures). However, while these results are promising, a
10-fold increase in the concentration of eosin-(KLAKLAK)2
caused significant photohemolysis of human red blood cells
(RBCs) and phototoxicity to certain cell lines. The photokilling
specificity achieved with eosin-(KLAKLAK)2 is therefore not ideal
and optimizing the activity of this compound further would
presumably be valuable for in vivo applications.
Figure 1. Experimental design of DAB photo-oxidation and visualization by TEM. (A) Light excitation of eosin-(KLAKLAK)2 results in
production of singlet oxygen and superoxide, which can polymerize DAB to provide an enhanced staining of osmium at the location of eosin-
(KLAKLAK)2. (B) Light irradiation has two purposes in this experiment, 1) to excite eosin-(KLAKLAK)2 for photodynamic activity (step 1), then following
fixation of samples, 2) to polymerize DAB at the location of the PS-AMP conjugate (step 4).
doi:10.1371/journal.pone.0091220.g001
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To improve the activity of eosin-(KLAKLAK)2, a path forward
involves understanding its mechanism of action as a basis for
future rational design. In this report, our goal was thus to gain a
molecular understanding of how eosin-(KLAKLAK)2 causes
bacterial photoinactivation. In particular, because AMPs such as
(KLAKLAK)2 are often thought to interact with bacterial lipid
bilayers, we test the hypothesis that eosin-(KLAKLAK)2 destroys
bacterial membranes. By exploiting DAB photooxidation and
STEM/EDS techniques for electron microscopy, we are able to
gain unprecedented visualization of a PS-AMP in its cellular
context. Additionally, bacteria killing and in vitro liposome assays
suggest plausible molecular targets, ROS mechanisms, and
molecular properties of eosin-(KLAKLAK)2 during bacterial
photoinactivation.
Materials and Methods
Materials
Fmoc amino acids and HBTU were purchased from Nova-
biochem, while solvents and chemicals were purchase from Sigma.
One exception was 5(6)-carboxy eosin Y, which was purchased
from Marker Gene Technologies. For liposome preparation, 1-
stearoyl-2-oleoyl-sn-glycero-3-phosphocholine (PC), cholesterol
(Chol), choline sphingomyelin (SM), dioleoyl-phosphatidyl etha-
nolamine (PE), L-a-Phosphatidyl-DL-Glycerol (PG), and cardio-
lipin (CA) were purchased from Avanti Lipids.
Solid Phase Peptide Synthesis
The antimicrobial peptide H2N-KLAKLAKKLAKLAK-NH2,
or ‘‘(KLAKLAK)2’’ was synthesized by Fmoc chemistry, as
described previously. [41] The conjugate eosin-(KLAKLAK)2
was obtained by coupling of 5,6-carboxy-eosin Y to the N-
terminus of the peptide. The compound was purified by reversed-
phase C18 HPLC and characterized by MALDI-TOF, as
described previously [41].
Light Source for Photodynamic Experiments
Irradiation was achieved using a homemade setup with a 600 W
halogen lamp (Utilitech #0320777). [41] To prevent overheating
of the lamp, the glass face was removed and air-cooled during
operation. The lamp was suspended over a homemade water filter
to remove heat from infrared wavelengths by continuous exchange
of the water supply. A stir plate was placed underneath the water
filter to hold samples during illumination. Samples were placed in
wells of a 96-well plate with micro stir bars and a lid. A 567 inch
green filter (Edmund Optics cat. no. NT46–624, 470–550 nm
FWHM) was placed on top of the lid for excitation of eosin. A
single pane of 1/16 inch diffusing glass was placed on top of the
green filter to provide an even distribution of light intensity.
Experiments detecting the 1O2 production from Rose Bengal via
reaction with RNO (p-nitrosodimethylaniline) demonstrated that
this setup provides even distribution of light across all 96 wells
(data not shown). Samples were stirred at 200 rpm and set at a
distance of 20 cm from the light source. Irradiance at this distance
through all filters was 131 mW/cm2 (,236 J/cm2 for a 30 min
exposure) as determined with a Newport 840-C optical power
meter. For experiments with Ce6, a similar red filter was used
(Edmund Optics cat. no. NT46–622, ,625 nm cut-on filter).
Bacterial Strains
Escherichia coli BL21 DE3 was obtained from Agilent, and
Staphylococcus aureus subsp. aureus (ATCC 29213) was purchased
from the American Type Culture Collection. E. coli and S. aureus
were grown in Luria-Bertani broth (LB). Glycerol stocks were
established for each strain and used to streak agar plates. Colonies
from plates were used to inoculate overnight cultures that were
grown aerobically at 37uC. Fresh cultures were inoculated the next
day in a 1:1000 dilution of overnight culture and used for
experiments after growth to mid log phase (O.D.600 ,0.4–0.6,
corresponding to ,109 CFU/ml).
Photooxidation, Fixation, and DAB Polymerization in
Bacteria Samples
Samples of E. coli or S. aureus were prepared in the same manner
used previously for phototoxicity experiments [41]. Cultures were
grown overnight in LB broth and fresh subcultures were prepared
in the morning. After growth to O.D.600 ,0.6, the cells were
pelleted and resuspended in phosphate buffer (100 mM NaCl,
10 mM Na2HPO4, pH 7.4), and this wash procedure repeated
once more. The stock suspension was diluted to an O.D.
which gave approximately 108 CFU/ml for each strain. Eosin-
(KLAKLAK)2 (22 ml of 10 mM), or H2O as a blank, was added to
wells of a 96 well plate before addition of 200 ml of bacteria
suspension in phosphate buffer (108 CFU/ml). Samples were
prepared in duplicate and kept in the dark for 2 min or
illuminated under the halogen lamp assembly mentioned above
for 2 or 5 min. Acrolein (100 ml of 2% solution) was then added to
samples and incubated at room temperature for 20 min to fix the
bacteria and any bound eosin-(KLAKLAK)2. To remove unbound
eosin-(KLAKLAK)2, the samples were transferred to microcen-
trifuge tubes and pelleted in a small bench top centrifuge for
5 min. The supernatant was removed and samples were washed
twice with 100 ml of cold 0.1 M cacodylate buffer. The pellets
were then resuspended in the same buffer supplemented with
0.1 M glycine to react with any remaining acrolein in solution,
and allowed to stand for 20 min before addition of 100 ml of
diaminobenzidine (DAB) buffer (1 mg/ml DAB in cacodylate
buffer). These suspensions were transferred to a 96 well plate for
15 min illumination to polymerize DAB specifically in the
locations where the peptide was fixed, followed by an additional
100 ml of DAB buffer and 15 min of illumination. Samples were
then transferred back to microcentrifuge tubes and washed twice
with cacodylate buffer, followed by suspension in cacodylate buffer
containing 1% (wt/vol) osmium tetroxide.
Electron Microscopy Sample Preparation and Imaging
After suspension of cells in osmium tetroxide, samples were
dehydrated with 10% steps of methanol to (10%–100%),
infiltrated overnight, and embedded in Quetol 651-Spurr epoxy
resin [42] and polymerized overnight. Thin sections (200–250 nm)
were cut with a Microstar diamond knife, (Huntsville, TX) using
an AO Ultracut ultramicrotome picked up on grids which were
carbon stabilized with approximately 10 nm of carbon using a
Cressington 308 evaporative coater. Bright field images were
obtained using a JEOL 1200 EX TEM (tungsten filament electron
gun, 120 keV accelerating voltage). For each sample,,25–50 cells
were imaged, and representative images were chosen for each
population. Elemental analysis was performed on an FEI
TECNAI F20 Super Twin (scanning) transmission electron
microscope ((S)TEM) fitted with a Schottky field emission gun, a
high angle annular dark field (HAADF) detector, and an EDAX
instrument ultrathin window energy dispersive X-ray spectroscopy
(EDS) detector. The combination of STEM and EDS allows direct
imaging of a nanoscale area and in situ identification of component
elements. Darkfield images were taken by the HAADF detector in
STEM mode. Approximately 40 cells were imaged in this manner
before selecting duplicate representative cells for EDS analysis.
Representative EDS data from a single sample was chosen for
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publication. An EDS spectrum at each spot in the area of interest
was collected at a 200 kV accelerating voltage and a ,15u tilting
angle with a stationary electron probe in STEM mode to see
component elements. Elemental line profiles were then acquired
after choosing a proper energy window for each element-specific
energy transition.
In vitro Detection of Singlet Oxygen and Superoxide
Production
Detection of singlet oxygen from eosin Y or eosin-(KLAKLAK)2
was achieved by irradiation in the presence of imidazole and RNO
(p-nitrosodimethylaniline) [43]. Production of singlet oxygen from
eosin Y leads to reaction with imidazole to form a peroxide
intermediate, which subsequently reacts with RNO to cause
bleaching of RNO absorbance. A total reaction volume of 200 ml
was obtained by addition of 20 ml each of 10X solutions for RNO,
imidazole, quencher (or H2O blank), PS or PS-AMP (or H2O
blank), and 120 ml phosphate buffer (10 mM phosphate, pH 7.4,
100 mM NaCl). Final concentrations were 50 mM RNO, 8 mM
imidazole, 100 mM sodium azide, and eosin Y or eosin-
(KLAKLAK)2 at 1 or 10 mM. Illumination was carried out in
the same manner as bacterial killing experiments to ensure
relevant results. Bleaching of RNO was detected at 450 nm using
a Glomax Multi+Plate reader.
Figure 2. Localization of eosin-(KLAKLAK)2 in S. aureus and E. coli samples determined by DAB photooxidation. Control samples
without eosin-(KLAKLAK)2 are shown in the top row. For remaining samples, eosin-(KLAKLAK)2 was incubated with cells, then irradiated for 0, 2, or
5 min (2nd, 3rd, and 4th rows, respectively) before fixation with acrolein, anchoring the bound eosin-(KLAKLAK)2 in place. Cells were then washed and
a second illumination was performed in the presence of DAB (1 mg/ml), producing an osmiophilic polymer for enhanced contrast by TEM at the site
of eosin-(KLAKLAK)2. To facilitate sample comparison, intensity surface plots were rendered from the 8-bit images shown, using a FIRE LUT and the
surface plot tool in ImageJ. All scale bars are 0.1 mm.
doi:10.1371/journal.pone.0091220.g002
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Detection of superoxide was achieved by excitation of eosin Y
and eosin-(KLAKLAK)2 in the presence of NADH and NBT
(nitro blue tetrazolium). A total reaction volume was obtained with
10X stock solutions in the manner mentioned above for the RNO
assay. Final concentrations for eosin Y or eosin-(KLAKLAK)2
were 1 or 10 mM, 10 mM NADH, and 80 mM NBT. Illumination
was carried out in the same manner as bacterial killing
experiments. Reduction of NBT resulting in the production of a
formazan was detected by absorbance at 600 nm using a plate
reader. Since the RNO and NBT reactions proceed by oxidation
and reduction, respectively, there is no cross talk between the
assays [33,44].
Bacterial Killing Experiments with ROS Quenchers
Bacterial killing experiments were carried out in the same
manner as described previously [41]. Peptide and quencher
solutions were placed in wells of a 96 well plate, composed of 11 ml
of 20X quencher with and without 11 ml of 20X eosin-
(KLAKLAK)2 or H2O blanks where appropriate, before addition
of 200 ml of bacteria culture (108 CFU/ml). Crocetin was used
from a 100X stock in DMSO, requiring only 2.2 ml of stock in the
same total volume of 222 ml. Samples were allowed to incubate for
approximately 3–5 min before irradiation to allow for peptide
binding, and micro stir bars (262 mm, Cowie via Fisher) were
added for continued aeration during irradiation. The lipid to
peptide (L/P) ratio under these conditions is 1:1 when the peptide
or PS concentration is approximately 3 mM (these calculations
assume 256106 lipids per bacteria). Samples were irradiated with
the same setup described above with a 30 min exposure for each
sample.
After samples were illuminated for 30 min, 30 ml of each sample
was added to 270 ml of phosphate buffer in a separate 96-well
plate. Further 10-fold serial dilutions of the samples were made in
phosphate buffer to give samples ranging from 101–105 in dilution
factor. From each dilution, 50 ml was removed and spread on an
agar plate, then incubated overnight at 37uC. Colonies were
counted the next morning to determine the remaining CFU/mL.
Plates without peptide treatment were included as a negative
control for sample comparison to determine percent survival.
Liposome Preparation
Large unilamellar vesicles (LUVs) of two compositions were
prepared to represent the lipids and net surface charge of human
[45,46] and bacterial (Gram negative E. coli [47] and Gram
positive S. aureus [48]) membranes. The human (Hum) LUVs were
a 50/30/20 ratio of PC/Chol/SM. The bacterial (Bac) compo-
sition was 75/20/5 of PE/PG/CA. The outer membrane of S.
aureus presents a significantly greater negative charge than this
composition due to higher PG content (.75%), no PE, and little
lysyl PG (3%) [48]. These Bac LUVs therefore present a lower
threshold of negative charge, and likewise, charge-based attraction
for the cationic (KLAKLAK)2. Since the ROS produced by
photooxidation mechanisms target carbon-carbon double bonds
[49], the double bond content should also be noted in the design.
The PC, Chol, and SM component of Hum LUVs each contain
one double bond. The PE and PG lipids of Bac LUVs also have a
single unsaturation. CA has four double bonds per molecule but
represents only 5% of the total LUV lipids, reflective of bacterial
composition [47,48]. Overall, for a LUV sample of 100 mmole
total lipid, there are therefore 100 mmole of unsaturated sites for
Hum LUVs and 115 mmole for Bac LUVs.
Stock lipids in chloroform were mixed in a glass vial for the
required molar ratios and the solvent evaporated under a nitrogen
stream. Lipid mixtures were then placed in a vacuum desiccator
for a minimum of 2 hrs before addition of phosphate buffer
(10 mM phosphate, pH 7.4, 100 mM NaCl; 60 mM calcein
included as needed for leakage assays). The lipids were then put
through ten freeze-thaw cycles between liquid nitrogen and a
water bath at 42uC to create multi-lamellar vesicles (MLVs). These
Figure 3. Bromine atoms from eosin-(KLAKLAK)2 serve as a
marker for detection by STEM-EDS in bacteria samples. (A)
STEM dark field image of S. aureus treated with eosin-(KLAKLAK)2 and
light for 2 min. (B) Elemental analysis by EDS for the square area
indicated in (A), showing the distinct presence of Br from eosin-
(KLAKLAK)2 (the transitions of C, O, P, and other elements are
predominant at lower energy levels and thus not seen here). (C) EDS
element profiles of the line scan depicted in (A), showing the coincident
intensities of Os, Br, and P elements at the interior, cell wall, and
extracellular material, with more than 250 counts for Br at the
membrane and extracellular regions.
doi:10.1371/journal.pone.0091220.g003
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MLVs were extruded twenty one times using an Avanti extruder
with a 100 nm polycarbonate membrane. For LUVs without
calcein, these were transferred to a glass vial for storage under
nitrogen at 4uC. LUVs with calcein required separation of external
dye by size exclusion chromatography using a Sephadex G-50
column in phosphate buffer. The calcein-loaded LUV prepara-
tions for both lipid compositions used for this manuscript were
stable for approximately two-four weeks when kept at 4uC. The
stability varies with lipid composition, and should be monitored in
each case. We monitored stability over time by measuring the
increase in fluorescence of calcein-loaded LUVs after addition of
0.1% Triton X-100 (final concentration), using a 200 ml sample of
200 mM total lipid. Samples were placed in a 96 well plate and
fluorescence determined with a Promega Glomax Multi micro-
plate reader. Ten-fold dilutions were made where needed to
ensure that no self-quenching remained in the detergent samples,
allowing for a linear comparison between samples.
Leakage Assays
For leakage experiments, stock solutions of calcein-loaded LUVs
were diluted as needed in phosphate buffer to obtain working
solutions of 200 mM total lipid. Wells of a 96 well plate were first
filled with 11 ml of 20X quencher or H2O blank, followed by 11 ml
of 20X eosin-(KLAKLAK)2 or H2O blank. A volume of 200 ml of
the 200 mM LUV working solution was then added to each well.
This mixture provides a 1X concentration of quencher and eosin-
(KLAKLAK)2, with 90% of the total lipid concentration in the
final solution. Samples were irradiated using the light source
described above, and calcein release was monitored by fluores-
cence with a plate reader (Ex 490, Em 510–570). Readings of all
samples were taken before irradiation for intensities at 0 min.
Leakage experiments testing the specific role of the (KLAK-
LAK)2 peptide in the lysis of bacterial (Bac) LUVs were performed
in a similar manner as described above. For experiments with
chlorin e6 (Ce6), Bac LUVs were kept in the dark or irradiated for
10 min with either a water blank or Ce6 (10 mM) alone. After the
first dark or irradiated step, a water blank or (KLAKLAK)2 (1, or
10 mM) was added to each sample for 20 min before reading the
fluorescence again to assess any additional leakage caused by
(KLAKLAK)2.
Fluorescence Anisotropy Measurements
Peptide and photosensitizer binding to LUVs can be described
by K, the apparent molar partition coefficient [50,51]. The total
lipid concentration [L] during measurements was significantly
higher than peptide concentration bound to liposomes [P]b,
therefore binding can be defined as:
P½ b~K P½  L½  ð1Þ
where [P] is the free molar peptide concentration in solution.
Since the peptide or photosensitizer could potentially cross the
membrane, [L] is the total lipid concentration in solution.
Substitution of [P] in equation (1) with [P]tot-[P]b, followed by
algebraic rearrangement leads to an expression of fraction bound
([P]b/[P]tot):
P½ b
P½ tot
~
K L½ 
1zK L½  ð2Þ
To obtain values of K, binding of peptide or photosensitizer was
determined by titration with model LUVs of bacterial or
mammalian lipid composition, and the fluorescence anisotropy
recorded for different total lipid concentrations. Fluorescence
anisotropy measurements were recorded in L-format using a
SLM-8000C fluorometer (SLM Instruments, Bath, UK) with the
Phoenix package (ISS, Champaign, IL) and Vinci v.1.6 PC
software (ISS). Samples were excited at 525 nm and emission
detected through a 560 cut-on filter for eosin Y and eosin-
(KLAKLAK)2, or a 590 cut-on filter for Ce6, using 0.5 mm slits on
each side. To remove scattering background, blank titrations were
performed with LUVs alone. The parallel and perpendicular
emission intensities (vertical-vertical and vertical-horizontal polar-
izer positions, respectively) of the blanks were subtracted from
those of the samples at each lipid concentration, before calculation
of the steady state anisotropy (r) using the equation:
r~
IVV-G  IVH
IVVz2 G  IVH ð3Þ
Figure 4. Eosin-(KLAKLAK)2 lyses LUVs of bacterial lipid composition, but not of mammalian composition. Eosin-(KLAKLAK)2 (10 mM)
was mixed with LUVs (200 mM) of (A) ‘‘Human’’ (Hum) or (B) ‘‘Bacterial’’ (Bac) lipid composition, each containing a self-quenching concentration of
calcein (60 mM). Samples were irradiated for the times indicated and leakage was detected as an increase in fluorescence intensity after release of
calcein and subsequent unquenching. Average values are shown for triplicate experiments with error bars representing the standard deviation.
doi:10.1371/journal.pone.0091220.g004
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where the subscript pairs denote the vertical (V) or horizontal (H)
orientation of the excitation and emission polarizers, respectively,
for the detected intensities (I). The instrument-specific parameter
G = IHV/IHH corrects for detector sensitivity to vertically and
horizontally polarized light [52]. Titrations were repeated at least
twice to obtain average r values for each point. To correct for
changes in quantum yield after binding to membranes and also
account for the contribution of anisotropy from free and bound
forms, the fraction bound fB was calculated using the equation:
fB~
(r-rF)
(r-rF)zR(rB-r)
ð4Þ
where rF and rB are the anisotropy values for fully free and bound
(saturated) states, r is the anisotropy value at each titration step,
and R = IB/IF is the ratio of total intensities from the bound
(saturated) and free states, respectively. Total intensity was
calculated as shown in the denominator of equation 3, and all
values were corrected for dilution resulting from titration. Binding
curves were plotted and fit to a single site-specific binding model
with Hill slope using GraphPad Prism v.6 software. The reciprocal
of K, the dissociation constant Kd, was obtained from the curve
fits for comparison of binding affinities. Kd values describe the
total molar concentration of lipid in solution required to achieve
50% fraction bound for the fluorophore or peptide.
Statistical Analysis
Data were processed using Microsoft Excel. Experiments were
performed in triplicate unless otherwise noted. The average values
of three or more replicate experiments were computed with error
bars representing the standard deviations. In order to curve fit the
binding anisotropy data, average anisotropy and standard
deviation values were transferred into GraphPad Prism. This
program computes the value and error of Kd based on the curve
fit of the averaged data and the corresponding error values.
Results
Eosin-(KLAKLAK)2 Localizes to the Outer Surface of E. Coli
and S. Aureus in the Dark, and Subsequent Light
Excitation causes Membrane Disruption
To investigate the mechanism of bacterial photoinactivation by
eosin-(KLAKLAK)2, we first sought to determine where the
compound localizes in bacteria. To achieve this aim, the DAB
photooxidation methodology developed for TEM was adapted
herein [53,54]. In this approach, ROS-generating species can be
localized with high resolution by detecting the ROS-induced
polymerization of 3,3-diaminobenzidine (DAB). The DAB poly-
mer is osmiophilic and increased osmium staining at the site of
polymer formation is visualized as dark contrast by electron
microscopy [53,55]. Oxidizing ROS do not typically diffuse far
away from their site of generation and DAB polymerization is
therefore restricted to where the ROS-generating moiety is
[53,55]. Eosin Y has been previously used to induce DAB
polymerization [53]. We therefore expected that eosin-
(KLAKLAK)2 could also lead to DAB polymerization and that a
dark contrast visualized by EM would indicate where eosin-
(KLAKLAK)2 localizes in bacteria.
Figure 1 depicts the adapted DAB polymerization protocol
followed in our experiments [53,54,56]. Eosin-(KLAKLAK)2 was
mixed with E. coli or S. aureus and the samples were fixed with
acrolein. Control samples without eosin-(KLAKLAK)2 were also
prepared. The fixed samples were treated with DAB buffer and
illuminated with the filtered halogen lamp (Figure S1) to induce
DAB polymerization. The resulting DAB staining and cell
morphologies are shown by TEM images in Figure 2, along with
their corresponding intensity surface plot profiles for simplified
comparison. Samples treated with eosin-(KLAKLAK)2 show a
very dark contrast at the cell walls while cells not exposed to the
peptide do not (these samples are still treated with DAB and
irradiated).
Figure 5. Eosin-(KLAKLAK)2 binds to LUVs of bacterial, but not
human lipid composition. Model liposomes of bacterial (A) or
human (B) lipid composition were titrated into a solution of 1 mM eosin
Y or eosin-(KLAKLAK)2 to detect changes in anisotropy. The resulting
values were used to calculate the fraction bound and the data were fit
to a single-site binding model with Hill slope. Eosin-(KLAKLAK)2 showed
no change in anisotropy after addition of Hum LUVs.
doi:10.1371/journal.pone.0091220.g005
Table 1. Binding parameters derived after curve fitting to
anisotropy binding data.
Dissociation constant, Kd (mM)
Ligand Bacterial LUVs Human LUVs
eosin-(KLAKLAK)2 18.860.948 Binding not observed
eosin Y 1,9316183.4 800649.7
doi:10.1371/journal.pone.0091220.t001
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To visualize the photo-damage caused by eosin-(KLAKLAK)2
during bacterial photoinactivation, samples of eosin-(KLAKLAK)2
and bacteria were illuminated for 2 or 5 min prior to fixation.
Under these conditions, approximately 50% and 90% cell death is
obtained for both E. coli and S. aureus, as previously reported [41].
A longer irradiation time of 30 min results in a 5 log reduction
(99.999%) of the same cultures. Our rationale was that under
conditions of shorter irradiation time, the early stages of photo-
damage that lead to cell death would be observed as opposed to
photo-damage events that might take place well after cells are
dead. As shown in the third and fourth rows of Figure 2, light
irradiation of eosin-(KLAKLAK)2 prior to fixation, results in
membrane damage and lysis of the cell wall. At 2 min irradiation,
deformation of the cell wall of S. aureus can be observed. Under
similar condition, E. coli cells display rupture of the outer and inner
membranes. At 5 min irradiation, large structures with dark
contrast form on the surface of both strains and membrane
damage is more severe. It is also interesting to note that DAB
contrast diminishes in certain samples (e.g. E. coli at 2 min). This is
expected however as the eosin Y moiety of eosin-(KLAKLAK)2
will partially photobleach during the irradiation step required for
cell killing and thereby have a reduced ability to cause DAB
polymerization in subsequent steps.
In order to confirm that the enhanced osmium staining at the
cell surface of bacteria was in fact the result of the presence of
eosin-(KLAKLAK)2, scanning TEM (STEM) with energy disper-
sive X-ray spectroscopy (EDS) was used. STEM-EDS is a
methodology that can be used to analyze the distribution of select
atoms in biological samples [57,58]. Eosin Y contains four
bromine atoms per molecule. In contrast, bromine is a rare
element in most bacterial species and bromine is not detected by
STEM-EDS in E. coli or S. aureus [59]. Bromine can therefore act
as a specific marker for the location of eosin-(KLAKLAK)2 [60].
In Figure 3a an image of an S. aureus cell treated with eosin-
(KLAKLAK)2 and light for 2 min is shown. A white box depicts
the location of an area scan at what appears to be adjacent
membrane debris in the media, with the resulting elemental profile
shown in Figure 3b. Br atoms are detected, indicating the presence
of eosin-(KLAKLAK)2 in this extracellular debris. A white line is
also shown in Figure 3a which depicts the path of a line scan,
sampling the cell and extracellular debris for STEM-EDS analysis.
The intensity of bromine content is depicted along the path of the
line scan (from left to right) in Figure 3c. The bromine intensity is
Figure 6. Experimental design to determine the capacity of (KLAKLAK)2 for membrane lysis. Bac LUVs containing self-quenching
concentrations of calcein were first treated with light in the presence or absence of the PS Ce6, in order to mimic the lipid photooxidation that occurs
from irradiation of the eosin-(KLAKLAK)2 conjugate. The fluorescence intensity was recorded before and after irradiation to determine any leakage
caused by light alone (LLUV) or by irradiation of Ce6 (LCe6). Continual fluorescence readings after this point demonstrated that leakage did not persist
after the light was turned off (data not shown). A water blank, 1 and 10 mM (KLAKLAK)2 (final concentration) was then added in the dark and after
20 min, the fluorescence was read again to determine any additional leakage caused by (KLAKLAK)2. The synergy of (KLAKLAK)2 with Ce6 was
calculated with the equation shown.
doi:10.1371/journal.pone.0091220.g006
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greatest at the cell membrane and at the location of the adjacent
debris. Additionally, bromine intensity also correlates with that of
osmium.
Eosin-(KLAKLAK)2 causes Leakage of Liposomes of
Bacterial, but not Mammalian, Lipid Composition in the
Presence of Light
Eosin-(KLAKLAK)2 binds to and photo-destroys the cell walls
of both Gram positive and negative strains. ROS characterization
showed that both singlet oxygen (1O2) and superoxide (O2
N2)
might mediate these effects. This is based on dependence for
oxygen and inhibition of killing by ROS quenchers (Figure S2).
Additionally, both 1O2 and O2
N2 are generated by eosin-(KLAK-
LAK)2 (Figure S3). However, since eosin Y and eosin-(KLAKLAK)2
show similar ROS production at the low concentrations (1 mM) used
for bacterial killing, the activity of eosin-(KLAKLAK)2 cannot be
fully explained by ROS generation (eosin also binds to E. coli at
high concentration but does not induce cell killing [41]). In
order to gain further insights in the photo-killing mediated by
eosin-(KLAKLAK)2, it seemed reasonable to test how the
conjugate interacts with a common component of the two cell
walls, namely, the lipid bilayer. To test whether eosin-
(KLAKLAK)2 damages lipid bilayers upon irradiation, leakage
assays using calcein loaded LUVs were first performed (Figure 4).
Disruption of LUVs in this system results in the release of
calcein with subsequent un-quenching and an increase in
fluorescence. Calcein-loaded LUVs (100 nm diameter, 200 mM
total lipid) with or without eosin-(KLAKLAK)2 present in
solution (10 mM), were irradiated for 30 min under the same
conditions as bacterial killing assays. Values for 100% lysis were
determined by addition of 0.1% Triton X-100 to LUVs to
release the remaining calcein. LUVs with a lipid composition
representative of bacterial lipid bilayers were used along with
LUVs characteristic of human plasma membranes as a control.
These LUVs in particular differ in charge as the lipids of
bacterial (Bac) LUVs are negatively charged while the lipids of
mammalian (Hum) LUVs are neutral.
Figure 4a shows that light alone or the combination of light and
Eosin Y (10 mM) does not cause leakage for either type of LUV. In
contrast, irradiation of eosin-(KLAKLAK)2 leads to early and
continued leakage from Bac LUVs (Figure 4b), while no such
leakage was observed without irradiation. Interestingly, no leakage
was observed with Hum LUVs. After the addition of Triton X-
100, it is apparent that the total fluorescence of LUVs treated with
eosin-(KLAKLAK)2 is significantly diminished compared to LUVs
alone or with eosin Y, indicating significant bleaching of calcein
caused by eosin-(KLAKLAK)2 during irradiation. This suggests
that the apparent fluorescence of calcein (and thus apparent
leakage) throughout the irradiation process is actually underesti-
mated for eosin-(KLAKLAK)2 in this assay. The apparent leakage
during irradiation nonetheless provides a lower limit for the extent
of leakage achieved.
In order to establish why eosin Y and eosin-(KLAKLAK)2 differ
in activity and why eosin-(KLAKLAK)2 disrupts Bac LUVs but
not Hum LUVs, steady state fluorescence anisotropy was used to
test the binding of these compounds to LUVs (Figure 5). Addition
of Bac LUVs, but not Hum LUVs, to eosin-(KLAKLAK)2 resulted
in a significant increase in anisotropy. The data were best fit by a
single-site binding model with Hill slope, displaying an apparent
cooperativity as seen previously for lysine-containing peptides
binding to acidic liposomes [61,62]. As shown in Table 1, eosin-
(KLAKLAK)2 (net charge +6 at pH 7.4) associates with negative-
ly-charged Bac LUVs (Kd = 18.8+/20.948 mM). but not with
neutral Hum LUVs. In contrast, Eosin Y alone (net charge 22 at
Figure 7. Ce6 and (KLAKLAK)2 display synergistic leakage
activity towards Bac LUVs. (A) Bac LUVs in the presence or absence
of Ce6 were kept in the dark for 10 min before addition of 0, 1, or
10 mM (KLAKLAK)2. (B) Same as in (A), but samples were irradiated with
light for 10 min before addition of (KLAKLAK)2 (two-tailed t test, * = p,
0.05, ** =,0.01, *** = p,0.001). (C) Synergy of (KLAKLAK)2 and Ce6
leakage determined for light and dark conditions using values from (A)
and (B).
doi:10.1371/journal.pone.0091220.g007
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pH 7.4 [63]) binds to neutral Hum LUVs (Kd = 800+/
249.7 mM), and associates only weakly with negatively charged
Bac LUVs (Kd = 1,931+/2183.4 mM).
The AMP Component of the Eosin-(KLAKLAK)2 Conjugate
Actively Participates in Membrane Lysis
AMPs such as (KLAKLAK)2 are known to induce liposomal
leakage on their own at high P:L ratios. Moreover, it has been
recently shown that the ROS-induced oxidation of lipids can
enhance the lytic activity of cell-penetrating peptides [40]. We
therefore hypothesized that the peptide moiety of eosin-(KLAK-
LAK)2 might promote similar effects and accelerate the leakage of
LUV containing oxidized lipids. To test this hypothesis, the
experimental protocol presented in Figure 6 was followed. In this
scheme, liposomes were first pre-oxidized with the PS chlorin e6
(Ce6) (Figure S1) and subsequently treated with (KLAKLAK)2.
Unlike eosin Y, Ce6 binds Bac LUVs (Figure S4) and cause
leakage upon irradiation. Like eosin Y, Ce6 generates both singlet
oxygen and superoxide [33]. Ce6 was therefore used in place
of the eosin Y to cause the photo-oxidation of lipids in a
manner similar to what is obtained upon irradiation of eosin-
(KLAKLAK)2.
Leakage from Bac LUVs treated with Ce6 and irradiated for
10 min was first measured by monitoring calcein leakage, as
described in Figure 6. After this preliminary step, (KLAKLAK)2 (1
or 10 mM) was added to the samples and subsequent LUV leakage
was further monitored. In control samples, LUVs were irradiated
in the absence of Ce6 but subsequently treated with (KLAK-
LAK)2. The leakage obtained in irradiated samples treated with
both Ce6 and peptide was then compared to that obtained in
samples treated with peptide alone. In addition, parallel experi-
ments were performed without irradiation in order to assess the
membrane leakage that might simply happen by combining Ce6
and (KLAKLAK)2 in the dark.
Figure 7a shows the percent leakage of Bac LUV samples
prepared and kept in the dark for 10 min with or without Ce6
(dark gray and black bars, respectively) before subsequent addition
of a water blank or (KLAKLAK)2 (1 or 10 mM). Ce6 alone showed
no significant leakage activity while (KLAKLAK)2 led to only 3
and 1% leakage at 1 and 10 mM, respectively. Leakage in the
presence of both Ce6 and (KLAKLAK)2 was slightly greater, with
8% and 5% leakage obtained at 1 and 10 mM, respectively.
Interestingly, leakage was significantly enhanced upon irradiation,
as shown in Figure 7b. In particular, irradiation of LUVs
incubated with Ce6 alone displayed less than 2% leakage (the
irradiation dose was chosen so as to limit lysis by Ce6 alone).
Leakage with (KLAKLAK)2 alone was observed to be the same as
that observed in the dark, as expected for an agent that does not
depend on light for its activity. However, samples irradiated with
Ce6 and receiving a subsequent addition of (KLAKLAK)2
displayed significant enhancements in leakage over those observed
for Ce6 or (KLAKLAK)2 alone, with 12 and 13% leakage
observed at 1 and 10 mM, respectively.
In order to quantify the increased membrane disruption
observed upon combining Ce6 and (KLAKLAK)2, synergy was
calculated as the ratio LCe6+K/(LCe6+ LK), where LCe6, LK, and
LCe6+K, represent the percent leakage in the presence of Ce6 alone,
(KLAKLAK)2 alone, and with co-incubation of Ce6 and
(KLAKLAK)2, respectively. Where synergy exists, leakage ob-
tained by co-incubation of Ce6 and peptide should be greater than
the sum of what is obtained with each molecule alone and result in
a synergy with a value greater than 1. The results of the calculation
for each concentration of (KLAKLAK)2 are shown in Figure 7c.
Under these conditions, the addition of (KLAKLAK)2 results in a
synergistic leakage for both dark and light irradiated conditions.
This synergy increases with peptide concentration. The synergy
observed under irradiated conditions is greater than that observed
in the dark for both concentrations, and shows a greater
concentration dependent response with light irradiation. Overall,
these results indicate that (KLAKLAK)2 contributes to increasing
the leakage of photo-oxidized liposomes.
Discussion
In this investigation, we aimed to identify how the conjugate
eosin-(KLAKLAK)2, a compound containing both an ROS-
generator and an antimicrobial peptide, kills bacteria. To begin
our investigation, we first aimed to establish how eosin-
(KLAKLAK)2 associates with bacteria by using electron micros-
copy (EM) so as to image the distribution of peptide at relatively
high resolution. Immunogold staining has been recently used to
visualize an AMP by EM [64]. Yet, this approach might not
faithfully report on the distribution of a peptide as the relatively
large antibodies used for labeling might not be able to reach small
peptide targets in the matrix which results from the chemical
fixation of samples [53]. To circumvent this problem, we first
adapted the DAB photooxidation method to detect the localiza-
tion of the compound in bacteria. The DAB photooxidation
technique has previously been used to determine the localization
of large protein complexes [53] or lipophilic dyes [65], but to our
knowledge, has never before been used to elucidate information
about relatively small peptides. A concern in using this method
was that eosin-(KLAKLAK)2 might damage cells during DAB
polymerization and thus interfere with interpretation. However, in
samples not irradiated with light before fixation, the cell
morphology appears unaffected, suggesting that the cell is
protected from visible damage by the acrolein fixation step that
precedes the irradiation required for DAB polymerization.
Additionally, control samples without eosin-(KLAKLAK)2 showed
no contrast, despite also being treated with DAB and irradiated,
demonstrating that eosin-(KLAKLAK)2 was essential, and that
light and DAB alone did not contribute to the contrast. Since DAB
photooxidation is a secondary detection method, the presence of
Br in the structure of eosin Y was also used to detect eosin-
(KLAKLAK)2 by STEM-EDS. Notably, the peaks of bromine
intensity were found to correlate with those of osmium. This in
turn suggest that the regions of dark contrast observed in Figure 2
represent regions where eosin-(KLAKLAK)2 is located, as opposed
to DAB polymerization occurring at a distant location from eosin-
(KLAKLAK)2. Overall, these results therefore demonstrated that
the DAB photooxidation approach could be successfully applied to
this problem. Additionally, while the current study specifically
investigates a conjugate with a PS in its native structure, analogous
applications of DAB photooxidation and STEM/EDS may also
have broad implications for understanding how AMPs and their
peptidomimetic counterparts act against a variety of clinically
relevant microbes.
DAB photooxidation experiments revealed that the vast
majority of eosin-(KLAKLAK)2, is localized to the surface of
Gram negative E. coli, suggesting interaction with the LPS-rich
outer membrane. However, similar binding was also observed for
Gram positive S. aureus, suggesting that components other than
LPS might also be capable of interacting with eosin-(KLAK-
LAK)2. Subsequent light irradiation resulted in cell wall damage to
both strains. In particular, disruption of the cytoplasmic
membrane could be observed in both strains, indicating that lysis
of this membrane might be a primary mechanism of cell death.
Given that the lipid components of bacterial cell membranes are
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thought to play a significant role in the activity of both
photosensitizers [66,67] and AMPs [68–70], we next tested the
binding and leakage activity of eosin-(KLAKLAK)2 towards LUVs
of bacterial lipid composition. Additionally, since eosin-(KLAK-
LAK)2 displays a selective killing of bacteria over human cells [41],
LUVs of mammalian lipid composition were tested as controls.
The lipids chosen for Bac LUVs were PE:PG:CA (75:20: 5), a
composition that mimics the negatively charged lipid bilayers of
E.coli [47] and S. aureus [48]. In contrast, the membrane
composition chosen for human lipid bilayers was PC:Chol:SM
(50:30: 20), a composition consistent with the outer leaflet of the
plasma membrane of human hepatocytes [45,46] and similar to
human red blood cells [71,72], which show closer to equal levels of
PC and SM. While cholesterol might contribute to stabilizing the
lipid bilayer, the cholesterol peroxides formed upon reaction with
ROS are well-known to be lytic [73]. The Hum LUVs prepared
should therefore be susceptible to oxidative damage and lysis.
Importantly, unsaturated fatty acids are also known to be oxidized
by ROS and their oxidation contributes to lipid bilayer lysis
[66,67]. The number of potential oxidizable unsaturated bonds
between Hum and Bac LUVs was therefore chosen to be within
the same order of magnitude (,50% of fatty acid chains contain
one unsaturation). These unsaturation levels are also representa-
tive of the unsaturation levels present in human membranes
(,50% of fatty acid chains, plus cholesterol) [71] or in the
membrane of E. coli (50–55%) [74]. It is important to note
however that only 2–4% of the fatty acids present in S. aureus are
monoenoic [75,76]. Our Bac LUVs are therefore presumably less
representative of the complex lipid bilayer of this bacterium. Yet,
S. aureus also contains unsaturated menaquinones with eight
isoprene units, thereby greatly increasing the total amount of
oxidizable sites [77]. Admittedly, the propensity for oxidation of
each lipid as well as their propensity to induce lipid bilayer
disruption might be very different. However, these factors remain
largely uncharacterized. With these limitations in mind, our Hum
and Bac LUVs should therefore be viewed as simplified membrane
models with comparative value.
Eosin-(KLAKLAK)2 showed binding to bacterial LUVs, but not
to human LUVs. This is consistent with the notion that the
positively charged peptide preferentially interacts with negatively
charged lipid bilayers rather than zwitterionic bilayers represen-
tative of the outer leaflet of human membranes [78]. In addition,
irradiation of eosin-(KLAKLAK)2 caused leakage of bacterial
LUVs but did not affect human LUVs. This is turn validates the
notion that the lipid bilayer of bacteria is a potential target of the
activity of eosin-(KLAKLAK)2. These results also provide a
possible explanation for the selectivity observed in light-induced
photo-killing. Interestingly, eosin Y alone showed little binding
to bacterial LUVs (,100 fold lower affinity than eosin-
(KLAKLAK)2) and did not cause leakage upon irradiation.
Because Eosin Y and eosin-(KLAKLAK)2 were found to generate
ROS in similar yields (Figure S2), these results indicate that
(KLAKLAK)2 increases the photolytic activity of Eosin Y by
bringing the PS in close proximity to the lipid bilayer.
Additionally, these data suggest that ROS generated in solution
by unbound eosin Y or eosin-(KLAKLAK)2 do not contribute
significantly to leakage.
The LUV binding and leakage results herein support the
conclusions of our previous work [41], where eosin-(KLAKLAK)2
displayed a strong preference for binding and damaging bacterial
cells over mammalian cells. In particular, while irradiation of
eosin-(KLAKLAK)2 at high concentration (.5 mM) can cause
hemolysis, the conjugate does not significantly bind to or lyse red
blood cells at concentrations sufficient to kill bacteria (e.g. 1 mM).
Moreover, irradiation of eosin-(KLAKLAK)2 yielded little to no
toxicity toward the human cell lines COLO 316 and HaCaT (up
to 10 mM). However, it is interesting to note that the viability of
COS-7 treated with 5 and 10 mM eosin-(KLAKLAK)2 then
irradiated with light was dramatically reduced in comparison to
the other cell lines. The decreased viability of COS-7 may suggest
a relatively more susceptible lipid composition, or alternatively, the
presence of other cellular factors which increase sensitivity to
eosin-(KLAKLAK)2 photooxidation.
The cell-penetrating peptides TAT and R9 have recently been
shown to promote the lysis of oxidized membranes [40,79].
Although the CPPs alone caused little lysis to RBCs, their addition
to RBCs during or after irradiation with rose bengal, enhanced
RBC lysis. These peptides thereby displayed a latent membrane
disrupting activity towards oxidized membranes. Because AMPs
and CPPs possess some structural and functional similarities [80],
and because AMPs have an intrinsic lytic activity, we tested the
hypothesis that synergy might also take place with (KLAKLAK)2.
To test for synergy, we examined the leakage of calcein from
liposomes of the same bacterial composition used for binding
experiments. Liposomes were first irradiated with Ce6 to oxidize
the lipid bilayers before addition of (KLAKLAK)2. The resulting
leakage was compared with that caused by the PS or AMP alone
to calculate potential synergy. Interestingly, a synergistic effect was
observed when LUVs pre-oxidized by irradiation of Ce6 were
then treated with (KLAKLAK)2. This result suggests that the PS-
AMP conjugate eosin-(KLAKLAK)2 might display a similar
behavior during photoinactivation of bacteria. For example, one
might envision a sequence of events where 1) binding and
specificity is first dictated by the AMP, 2) irradiation leads to
production of 1O2 and O2
N2 and thus oxidation of the membrane,
3) resulting in an increased susceptibility of the membrane to the
lytic activity of (KLAKLAK)2. Additionally, membrane disruption
by (KLAKLAK)2 could expose new targets to subsequent
photodynamic damage, continuing this potential cycle until targets
are exhausted or the PS-AMP itself is rendered ineffective by its
own ROS production or cellular degradation.
Together, our results establish that eosin-(KLAKLAK)2 associ-
ates with the cell wall of both Gram positive and Gram negative
bacteria. Upon irradiation, eosin-(KLAKLAK)2 is capable of
destroying membrane components. In particular, disruption of
lipid bilayers is observed by EM, and the photo-destruction of
liposomes of bacterial lipid composition can be achieved in vitro.
While eosin Y produces ROS, the peptide moiety (KLAKLAK)2
appears to drive the association of the PS with membrane lipids.
Interestingly, (KLAKLAK)2 is also capable of accelerating lipid
bilayer lysis once photo-oxidation of lipids is initiated, presenting a
remarkable duplicity to the nature of (KLAKLAK)2 interaction
with membranes.
Our data suggests that one of the roles played by (KLAKLAK)2
is a targeting agent for membrane binding, which is expected since
AMPs are well known to interact with and disrupt bacterial lipid
bilayers and model lipid systems. Accumulation of AMPs at the
membrane surface is typically electrostatically driven in bacteria
and liposome models, and can cause membrane disruption by
differing mechanisms upon reaching a critical peptide to lipid (P:L)
ratio [68]. MD simulations with micelle models also predicted that
a short amphipathic helical AMP could deform negatively charged
SDS micelles without affecting neutral micelle structure [81]. The
P:L ratios for the bacterial killing experiments herein are 1–2
orders of magnitude lower than required to achieve killing in the
dark [41], suggesting that under these conditions, (KLAKLAK)2
initially serves only as a targeting agent. Furthermore, eosin-
(KLAKLAK)2 does not cause leakage to Bac LUVs in the dark.
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Based on the binding affinity of eosin-(KLAKLAK)2 measured
with Bac LUVs, one molecule is bound for every 22 lipids under
the conditions used for LUV leakage experiments. If we assume
that the membrane is not crossed by the peptide and consider only
the outer leaflet, this corresponds to 11 lipids for every bound
peptide. Using the dimensions of lipids (65 A˚2, ,9 A˚ diameter)
[82] and a 14a.a. helix (21 A˚ long, ,18 A˚ wide if lysine side chains
extend in opposing directions for a 180u polar face [83]), one can
estimate that the peptide alone would occupy an area close to that
of 5 interspaced lipids. With eosin attached, the structure is
extended by ,10 A˚ in length and width, so that the eosin-
(KLAKLAK)2 structure would occupy the area of,7 lipids. These
numbers suggest that eosin-(KLAKLAK)2 occupied approximately
two-thirds of the membrane surface. However, despite this high
density, no leakage is observed in the dark, supporting the idea
that the (KLAKLAK)2 moiety serves, at least initially, only as a
targeting agent and is otherwise inactive before membrane
oxidation occurs.
In addition to membrane targeting, our data suggests that
(KLAKLAK)2 might play another important role by accelerating
the disruption of oxidized membranes. Interestingly, oxidized
lipids can also display a lytic activity on their own [67]. It would
therefore seem that the latent membrane disrupting activity of
(KLAKLAK)2 is amplified by oxidation of lipids, or that,
conversely, the lytic activity of oxidized lipids is amplified by the
AMP. The precise molecular details involved in this synergy
remain to be characterized. Nonetheless, these findings are
important as they lead to new hypotheses on how to increase
the activity of PDI agents. Future studies will examine the
potential of rationally designed conjugates for therapeutic appli-
cations. In addition, it is interesting to note that ROS production
and oxidative damage take place in bacteria constitutively [84,85].
It is therefore interesting to speculate that oxidized lipids present in
bacterial membranes might be involved in bacterial cell death
observed upon exposure to AMPs in general (in the dark).
Supporting Information
Figure S1 Spectral properties of lamp, filters, and
reagents. (A) Halogen lamp emission spectra through water
(heat sink) and color filters (shorter wavelengths limited by
detector). (B) Normalized absorbance of eosin-(KLAKLAK)2 and
eosin Y (left axis), and transmittance of the green filter alone (right
axis) used for their excitation. (C) Normalized absorbance of Ce6
(left axis), and transmittance of the applied red filter alone (right
axis).
(TIF)
Figure S2 Role of ROS in eosin-(KLAKLAK)2 (‘‘PS-
AMP’’)-mediated killing of S. aureus (A) and E. coli (B).
Samples (108 CFU/ml) were irradiated with light for 30 min.
Serial dilutions were made for colony counting and the survival
fraction determined by comparison with non-irradiated controls.
Samples without the PS-AMP are included to indicate the toxicity
of the quenchers alone. A protective effect against eosin-
(KLAKLAK)2 by the quencher is indicated by a survival fraction
that is greater than the control. Where the quencher alone is non-
toxic, yet enhances killing in the presence of eosin-(KLAKLAK)2,
the quencher could be protecting eosin-(KLAKLAK)2 from self-
bleaching. (N2): Partial displacement of O2 was achieved by
bubbling N2 into the re-suspension buffer. (Imidazole, 50 mM):
soluble 1O2 quencher. (Crocetin, 50 mM): membrane-soluble
1O2
quencher. (Tiron, 10 mM): soluble O2
N2 quencher; also chelates
ions, resulting in cell death to E. coli. (Mannitol, 50 mM): soluble
HON quencher. Both strains are protected after oxygen displace-
ment, supporting a direct role for O2 in the PDI mechanism (
1O2,
Type II), emphasized by crocetin protection (and imidazole in the
case of E. coli). Additionally, the significant protection of S. aureus
by Tiron also indicates a Type I (O2
N2) PDI mechanism at work.
Although eosin Y is known to produce both 1O2 and O2
N2, their
prospective roles in toxicity have not been demonstrated for eosin-
(KLAKLAK)2, and interestingly, eosin Y alone displays no
toxicity.
(TIF)
Figure S3 Detection of 1O2 and O2
N2 production from
eosin-(KLAKLAK)2 and eosin Y. (A) Relative production of
1O2 from eosin Y and eosin-(KLAKLAK)2 detected by oxidation
of RNO in the presence of imidazole. Addition of NaN3, a
quencher of 1O2, results in a large reduction of the response. (B)
Relative production of O2
N2 from eosin Y and eosin-(KLAK-
LAK)2 detected by reduction of NBT to blue formazan in the
presence of NADH, and specific quenching of O2
N2 by Tiron.
(TIF)
Figure S4 Ce6 binds to Bacterial (Bac) LUVs. Ce6 (1 mM)
was titrated with Bac LUVs in triplicate and the anisotropy data
was recorded. The fraction bound was calculated and plotted as
averages with their standard deviation. The data was fit to a single
site binding model with Hill slope in order to compare with eosin-
(KLAKLAK)2.
(TIF)
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